Global Primary Biliary Cirrhosis Drug Market Study 2016-2026, by Segment (Budesonide, FFP-104, … …), by Market (Clinic, Hospital, … …), by Company (AlbireoPharma, CymaBay Therapeutics, Inc., … …)
SKU ID :99ST-14632224 | Published Date: 28-Oct-2019 | No. of pages: 52Description
TOC
Table of Content
1 Industry Overview
1.1 Primary Biliary Cirrhosis Drug Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Primary Biliary Cirrhosis Drug Market by Type
2.1 By Type
2.1.1 Budesonide
2.1.2 FFP-104
2.1.3 GSK-2330672
2.1.4 MBX-8025
2.1.5 NGM-282
2.1.6 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 AlbireoPharma (Company Profile, Sales Data etc.)
5.2 CymaBay Therapeutics, Inc. (Company Profile, Sales Data etc.)
5.3 Dr. Falk Pharma GmbH (Company Profile, Sales Data etc.)
5.4 Enanta Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
5.5 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
5.6 Intercept Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
5.7 Johnson & Johnson (Company Profile, Sales Data etc.)
5.8 MediGene AG (Company Profile, Sales Data etc.)
5.9 NGM Biopharmaceuticals, Inc. (Company Profile, Sales Data etc.)
5.10 Virobay Inc. (Company Profile, Sales Data etc.)
6 Conclusion
Tables & Figures
List of Table
Table Global Primary Biliary Cirrhosis Drug Market 2016-2019, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2016-2019, by Type, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2026, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2026, by Type, in Volume
Table Global Primary Biliary Cirrhosis Drug Demand 2016-2019, in USD Million
Table Global Primary Biliary Cirrhosis Drug Demand 2016-2019, in Volume
Table Global Primary Biliary Cirrhosis Drug Demand Forecast 2020-2026, in USD Million
Table Global Primary Biliary Cirrhosis Drug Demand Forecast 2020-2026, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Size & Growth 2016-2019, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Size & Growth 2016-2019, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2026, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2026, in Volume
Table Global Primary Biliary Cirrhosis Drug Market 2016-2019, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2016-2019, by Region, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2026, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2020-2026, by Region, in Volume
Table AlbireoPharma Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AlbireoPharma Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CymaBay Therapeutics, Inc. Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Falk Pharma GmbH Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Enanta Pharmaceuticals, Inc. Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Plc Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intercept Pharmaceuticals, Inc. Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MediGene AG Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NGM Biopharmaceuticals, Inc. Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Virobay Inc. Overview List
Table Primary Biliary Cirrhosis Drug Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
List of Figure
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2019, by Type, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2019, by Type, in Volume
Companies
- PRICE
-
$1800$3600